![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sierra Natl BK Tehachapi Calif (MM) | NASDAQ:SIRT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 22.50 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 7, 2007
SIRTRIS PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-33465 |
|
20-1410189 |
|
(State or other
jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer
|
|
|
|
|
|
|
|
|
|
||||
790 Memorial Drive, Cambridge, Massachusetts |
02139 |
||||
(Address of Principal Executive Offices) |
(Zip Code) |
||||
Registrants telephone number, including area code: (617) 252-6920
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): |
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Definitive Material Agreement.
On November 7, 2007, Sirtris Pharmaceuticals, Inc. (Sirtris) entered into a first amendment (the Amendment) to the lease agreement between Sirtris and ARE-Tech Square, LLC, dated June 22, 2007 (the Lease) to, among other things, rent approximately 3,786 square feet of additional space at Sirtris new office and laboratory facility at 200 Technology Square, Cambridge, Massachusetts.
Under the Lease as amended, Sirtris will begin to make lease payments for the office space in December 2007 and for the new laboratory space in February 2008. The Lease term extends for a period of ten years at an initial annual rental rate is $58.50 per square foot and a minimum average annual rate of $68.63 per square foot over the lease term. Sirtris' payment obligations under the lease are secured by a $2.1 million standby letter of credit for the benefit of ARE-Tech Square, LLC. The standby letter of credit is secured by a $2.1 million certificate of deposit and is thereby restricted cash of Sirtris.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
See the description in Item 1.01 of Sirtris direct financial obligations under the Amendment, the Lease and the letter of credit for the benefit of ARE-Tech Square, LLC.
2
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
SIRTRIS PHARMACEUTICALS, INC. |
|
||
|
|
|
|
|
|
Date: November 9, 2007 |
|
By: |
/s/ Garen Bolin |
||
|
|
Name: |
Garen Bohlin |
|
|
|
|
Title: |
Chief Operating Officer |
|
|
3
1 Year Sierra Natl BK Tehachapi Calif (MM) Chart |
1 Month Sierra Natl BK Tehachapi Calif (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions